医学
胆囊
外科
胆管
胆道引流
胆道
胃肠病学
内镜逆行胰胆管造影术
内科学
存活率
并发症
排水
回顾性队列研究
胆囊切除术
内窥镜检查
胆囊管
作者
Antoine Debourdeau,Jérémie Albouys,Jocelyn Privat,Carme Loras,Jules Daniel,Marie Goudot,Jean‐François Bourgaux,Ludovic Caillo,Sergio Bazaga,Pierre Mayer,Romain Legros,Timothée Wallenhorst,Marion Schaefer,Bertrand Napoléon,Sarah Leblanc,Romain Gérard,Frédérick Moryoussef,Salomé Ouazana,Marine Camus,Nicolas Williet
出处
期刊:Endoscopy
[Thieme Medical Publishers (Germany)]
日期:2026-04-24
卷期号:58 (09): 978-988
被引量:4
摘要
Background Endoscopic ultrasound (EUS)-guided gallbladder drainage (EUS-GBD) is emerging as an alternative to choledochoduodenostomy (EUS-CDS) for malignant distal biliary obstruction (MDBO) after failed endoscopic retrograde cholangiopancreatography (ERCP). Comparative data on long-term patency are limited. Methods This retrospective international study analyzed two historical cohorts of patients who underwent EUS-GBD or EUS-CDS for MDBO after failed ERCP between March 2017 and May 2024. Eligible patients were aged ≥ 18 years with at least 6 months’ follow-up or confirmed death. The primary outcome, after 1 : 1 propensity score matching, was 12-month biliary patency. Secondary outcomes included technical and clinical success, adverse events (AEs), reintervention rates, and overall survival. Results Before matching, 294 patients were included (142 EUS-GBD; 152 EUS-CDS). After matching, 200 patients were analyzed (100 per group). Technical success was 100 % for EUS-GBD and 97 % for EUS-CDS (P = 0.25). Clinical success was 80.5 % for EUS-GBD and 90.6 % for EUS-CDS (P = 0.08). At 12 months, the probability of biliary patency was significantly higher with EUS-GBD than EUS-CDS (86.2 % [95 %CI 74.2 %–92.9 %] vs. 63.8 % [95 %CI 49.5–75.0]; P = 0.01). Biliary reintervention-free survival was significantly longer with EUS-GBD (log-rank, P < 0.001). Periprocedural AEs occurred in 7.0 % vs. 10.0 % (P = 0.61), delayed AEs in 27.0 % vs. 30.0 % (P = 0.75), and reintervention rates were comparable (23.0 % vs. 26.0 %; P = 0.74). Overall survival did not differ significantly (log-rank, P = 0.59). Conclusion In patients with MDBO after failed ERCP, EUS-GBD achieved higher 12-month biliary patency than EUS-CDS, with comparable rates of technical and clinical success, morbidity, reintervention, and overall survival.
科研通智能强力驱动
Strongly Powered by AbleSci AI